Prescription painkillers shortage in Canada expected to continue into new year
TORONTO — Pharmacists say a shortage of medications that contain oxycodone is expected to continue into the new…
Health Canada approves Ozempic® to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease
Ozempic® is the first-and-only medication indicated for both the once-weekly treatment of adult patients with type 2 diabetes…
Ozempic approved in Canada to reduce kidney decline in people with diabetes – National
Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2…